Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control

Homeopathy

Volumn 99, Issue 3, 2010, Pages 156-166

  Bracho, Gustavo ^a   Varela, Enrique ^b   Fernández, Rolando ^a   Ordaz, Barbara ^a   Marzoa, Natalia ^a   Menéndez, Jorge ^a   García, Luis ^a   Gilling, Esperanza ^c   Leyva, Richard ^c   Rufín, Reynaldo ^d   de la Torre, Rubén ^e   Solis, Rosa L ^a   Batista, Niurka ^a   Borrero, Reinier ^a   Campa, Concepción ^a  

^a FINLAY INSTITUTE   (Cuba)

^b Agromin Enterprise Group   (Cuba)

^c Provincial Centre for Homeopathy   (Cuba)

^d Provincial Centre for Epidemiology and Hygiene   (Cuba)

^e National Medical Services   (Cuba)

Author keywords

Cuba; Epidemics; Homeoprophylaxis; Leptospirosis; Prevention

Indexed keywords

HOMEOPATHIC AGENT; LEPTOSPIROSIS NOSODE; NOSOLEP; RAIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CUBA; DISEASE SURVEILLANCE; EPIDEMIC; INFECTION CONTROL; LEPTOSPIROSIS; MORBIDITY; NATURAL DISASTER; PROPHYLAXIS;

ADMINISTRATION, ORAL; BACTERIAL VACCINES; COHORT STUDIES; CUBA; DISEASE OUTBREAKS; HOMEOPATHY; HUMANS; INCIDENCE; LEPTOSPIRA; LEPTOSPIROSIS; POPULATION SURVEILLANCE; SEASONS; SOLVENTS; TREATMENT OUTCOME;

EID: 77955259301     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2010.05.009     Document Type: Article

References (43)

1. Pappas G., Papadimitriou P., Siozopoulou V., Christou L., Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis 2008, 12(4):351-357.
2. Vijayachari P., Sugunan A.P., Shriram A.N. Leptospirosis: an emerging global public health problem. J Biosci 2008, 33(4):557-569.
3. Cruz L.S., Vargas R., Lopes A.A. Leptospirosis: a worldwide resurgent zoonosis and important cause of acute renal failure and death in developing nations. Ethn Dis 2009, 19(1 Suppl 1). S1-S37-S41.
4. Margaletic J. Small rodents in the forest ecosystem as infectious disease reservoirs. Acta Med Croatica 2003, 57(5):421-426.
5. Adler B., de la Pena Moctezuma A. Leptospira and leptospirosis. Vet Microbiol 2010, 140(3-4):287-296.
6. Levett P.N. Leptospirosis. Clin Microbiol Rev 2001, 14(2):296-326.
7. Guerra M.A. Leptospirosis. J Am Vet Med Assoc 2009, 234(4). 472-478, 430.
8. Nachega J.B., Bottieau E., Zech F., et al. Travel-acquired scrub typhus: emphasis on the differential diagnosis, treatment, and prevention strategies. J Travel Med 2007, 14(5):352-355.
9. Sehgal S.C. Epidemiological patterns of leptospirosis. Indian J Med Microbiol 2006, 24(4):310-311.
10. Monahan A.M., Miller I.S., Nally J.E. Leptospirosis: risks during recreational activities. J Appl Microbiol 2009, 107(3):707-716.
11. Reis R.B., Ribeiro G.S., Felzemburgh R.D., et al. Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis 2008, 2(4):e228.
12. Palaniappan R.U., Ramanujam S., Chang Y.F. Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis 2007, 20(3):284-292.
13. Kobayashi Y. Human leptospirosis: management and prognosis. J Postgrad Med 2005, 51(3):201-204.
14. Kobayashi Y. Clinical observation and treatment of leptospirosis. J Infect Chemother 2001, 7(2):59-68.
15. Stoddard R.A., Gee J.E., Wilkins P.P., et al. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn Microbiol Infect Dis 2009, 64(3):247-255.
16. Brett-Major D.M., Lipnick R.J. Antibiotic prophylaxis for leptospirosis. Cochrane Database Syst Rev 2009, (3):CD007342.
17. Guidugli F., Castro A.A., Atallah A.N. Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev 2000, 4. CD001305.
18. Fitzgerald J. Availability of leptospirosis vaccine. Vet Rec 2009, 164(5):157.
19. Martinez Sanchez R., Obregon Fuentes A.M., Perez Sierra A., et al. The reactogenicity and immunogenicity of the first Cuban vaccine against human leptospirosis. Rev Cubana Med Trop 1998, 50(2):159-166.
20. Martinez R., Perez A., Quinones Mdel C., et al. Efficacy and safety of a vaccine against human leptospirosis in Cuba. Rev Panam Salud Publica 2004, 15(4):249-255.
21. Martinez Sanchez R., Perez Sierra A., Baro Suarez M., et al. Evaluation of the effectiveness of a new vaccine against human leptospirosis in groups at risk. Rev Panam Salud Publica 2000, 8(6):385-392.
22. Sanchez R.M., Sierra A.P., Obregon Fuentes A.M., et al. Reactogenicity and immunogenicity of Cuban trivalent inactivated vaccine against human leptospirosis in different vaccination schedules. Rev Cubana Med Trop 2002, 54(1):37-43.
23. Obregon A.M., Martinez G., Martinez R., et al. Serological response by ELISA and MAT in Cuban volunteers vaccinated with vax SPIRAL. Rev Cubana Med Trop 2004, 56(2):148-151.
24. Rodriguez I., Martinez R., Zamora Y., et al. Response of antileptospira IgG antibodies in individuals immunized with vax-SPIRAL. Rev Cubana Med Trop 2005, 57(1):32-37.
25. Wang Z., Jin L., Wegrzyn A. Leptospirosis vaccines. Microb Cell Fact 2007, 6:39.
26. Castro D., Nogueira G.G. Use of the nosode meningococcinum as a preventative against meningitis. J Am Inst Homeopath 1975, 68:211-219.
27. Leary B. The homoeopathic management of cholera in the nineteenth century with special reference to the epidemic in London, 1854. Med Ges Gesch 1997, 16:125-144.
28. Jonas W.B. Do homeopathic nosodes protect against infection? An experimental test. Altern Ther Health Med 1999, 5(5):36-40.
29. Mroninski C.R.L., Adriano E.J., Mattos G. Meningococcinum, its protective effect against meningococcal disease. Homoeopath Links 2001, 14(4):230-234.
30. Golden I. Vaccination & homoeoprophylaxis? A review of risk and alternatives 2005, Isaac Golden Publications, Canberra, (2007) 1-240. 6th edn.
31. Vickers A.J., Smith C. Homoeopathic oscillococcinum for preventing and treating influenza and influenza-like syndromes. Cochrane Database Syst Rev 2006, 3:CD001957.
32. Dean M. Comparative evaluation of homeopathy and allopathy within the Parisian hospital system, 1849-1851. J R Soc Med 2010, 103(1):34-36.
33. Pruna P.M. Homeopathic immunization against yellow fever in Havana, 1855. Asclepio 1991, 43(2):59-68.
34. de Almeida L.R., Campos M.C., Herrera H.M., et al. Effects of homeopathy in mice experimentally infected with Trypanosoma cruzi. Homeopathy 2008, 97(2):65-69.
35. Shah-Rossi D., Heusser P., Baumgartner S. Homeopathic treatment of Arabidopsis thaliana plants infected with Pseudomonas syringae. Scientific WorldJournal 2009, 9:320-330.
36. Watson J.T., Gayer M., Connolly M.A. Epidemics after natural disasters. Emerg Infect Dis 2007, 13(1):1-5.
37. Kawaguchi L., Sengkeopraseuth B., Tsuyuoka R., et al. Seroprevalence of leptospirosis and risk factor analysis in flood-prone rural areas in Lao PDR. Am J Trop Med Hyg 2008, 78(6):957-961.
38. Campanella N. Infectious diseases and natural disasters: the effects of Hurricane Mitch over Villanueva municipal area, Nicaragua. Public Health Rev 1999, 27(4):311-319.
39. Sanders E.J., Rigau-Perez J.G., Smits H.L., et al. Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1996 [correction of 1966]. Am J Trop Med Hyg 1999, 61(3):399-404.
40. Niwetpathomwat A., Niwatayakul K., Doungchawee G. Surveillance of leptospirosis after flooding at Loei Province, Thailand by year 2002. Southeast Asian J Trop Med Public Health 2005, 36(Suppl. 4):202-205.
41. Sehgal S.C., Sugunan A.P., Vijayachari P. Outbreak of leptospirosis after the cyclone in Orissa. Natl Med J India 2002, 15(1):22-23.
42. Tan H., Ping W., Yang T., et al. The synthetic evaluation model for analysis of flooding hazards. Eur J Public Health 2007, 17(2):206-210.
43. John T.J. The prevention and control of human leptospirosis. J Postgrad Med 2005, 51(3):205-209.